Cargando…
Interpretation of active-control randomised trials: the case for a new analytical perspective involving averted events
Active-control trials, where an experimental treatment is compared with an established treatment, are performed when the inclusion of a placebo control group is deemed to be unethical. For time-to-event outcomes, the primary estimand is usually the rate ratio, or the closely-related hazard ratio, co...
Autores principales: | Dunn, David T., Stirrup, Oliver T., McCormack, Sheena, Glidden, David V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294491/ https://www.ncbi.nlm.nih.gov/pubmed/37365584 http://dx.doi.org/10.1186/s12874-023-01970-0 |
Ejemplares similares
-
Confidence limits for the averted infections ratio estimated via the counterfactual placebo incidence rate
por: Dunn, David T., et al.
Publicado: (2021) -
The Connection between the Averted Infections Ratio and the Rate Ratio in Active-control Trials of Pre-exposure Prophylaxis Agents
por: Dunn, David T., et al.
Publicado: (2019) -
999. Using the F/TDF Adherence-Efficacy Relationship to Calculate Background HIV incidence: Results from the DISCOVER trial
por: Glidden, David V, et al.
Publicado: (2020) -
Using the adherence‐efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background hiv incidence: a secondary analysis of a randomized, controlled trial
por: Glidden, David V, et al.
Publicado: (2021) -
Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials
por: Dunn, David T., et al.
Publicado: (2023)